May 8, 2013, Billerica, MA — EMD Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany, was recognized with a Diabetes Champion award by the Juvenile Diabetes Research Foundation (JDRF).
Who: Christina Shasserre, Head of Discovery and Development Solutions for Bioscience at EMD Millipore.
What: Recognized with a Diabetes Champion Award from JDRF
When: May 4, 2013
Where: The JDRF Dream Gala at the Hyatt Regency at the Arch in downtown St. Louis
Why: Christina Shasserre was recognized for EMD Millipore’s support of JDRF, which includes serving as the chair sponsor of the annual “Walk to Cure Diabetes.” In addition to providing financial support, EMD Millipore employees participate and help to staff the annual walk in St Louis. “EMD Millipore's longstanding history of supporting scientific research is well aligned with JDRF's mission to find a cure for T1D," said Christina about the relationship. The Dream Gala raised $970,000 through silent auctions and ticket sales which will fund research to treat, cure, and prevent Type 1 Diabetes. EMD Millipore provides services to Pharmaceutical companies developing metabolic and other types of therapeutics and offers a portfolio of assays to detect metabolic biomarkers used in diabetes research.
About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA, Darmstadt, Germany, offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2012 revenues of €2.6 billion.
JDRF is the leading charitable funder and advocate of type 1 (juvenile) diabetes research worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is a disease which strikes children suddenly and requires multiple injections of insulin daily or a continuous infusion of insulin through a pump. Insulin, however, is not a cure for diabetes, nor does it prevent its eventual and devastating complications which may include kidney failure, blindness, heart disease, stroke, and amputation.
Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.16 billion to diabetes research, including more than $137 million in FY2007. In FY2007, the Foundation funded 700 centers, grants and fellowships in 20 countries.
The Greater Missouri & Southern Illinois Chapter was established in 1976 to promote the JDRF mission in metropolitan Saint Louis and western Illinois. Our coverage has expanded over the years to cover most of Missouri and a large portion of Illinois.